Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Chronic Heart Failure - Pipeline Review, H1 2016

ResearchMoz added Latest Research Report titled " Chronic Heart Failure - Pipeline Review, H1 2016 " to it's Large Report database.
Sagar Jagtap | 24.05.2016

Chronic Heart Failure - Pipeline Review, H1 2016

Summary

Global Markets Directs, Chronic Heart Failure - Pipeline Review, H1 2016, provides an overview of the Chronic Heart Failure pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Heart Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Heart Failure and features dormant and discontinued projects.

Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=719514

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Click to submit Query/ Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=719514


Table of Contents

Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Chronic Heart Failure Overview 9
Therapeutics Development 10
Pipeline Products for Chronic Heart Failure Overview 10
Pipeline Products for Chronic Heart Failure Comparative Analysis 11
Chronic Heart Failure Therapeutics under Development by Companies 12
Chronic Heart Failure Therapeutics under Investigation by Universities/Institutes 13
Chronic Heart Failure Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Chronic Heart Failure Products under Development by Companies 17
Chronic Heart Failure Products under Investigation by Universities/Institutes 18
Chronic Heart Failure Companies Involved in Therapeutics Development 19
Amgen Inc. 19
AnGes MG, Inc. 20
Bayer AG 21
Capricor Therapeutics, Inc. 22
Celyad SA 23
Juventas Therapeutics, Inc. 24
Laboratoires Pierre Fabre SA 25

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease

About the tenderer: Sagar Jagtap